Can active surveillance really reduce the harms of overdiagnosing prostate cancer? A reflection of real life clinical practice in the PRIAS study

BACKGROUND: Active surveillance (AS) for low-risk prostate cancer (PCa) appears to provide excellent long-term PCa-specific and overall survival. The choice for AS as initial treatment is mainly based on avoiding side effects from invasive treatment; but AS entails regular check-ups and the possibil...

Descripción completa

Detalles Bibliográficos
Autores principales: Drost, Frank-Jan H., Rannikko, Antti, Valdagni, Riccardo, Pickles, Tom, Kakehi, Yoshiyuki, Remmers, Sebastiaan, van der Poel, Henk G., Bangma, Chris H., Roobol, Monique J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861273/
https://www.ncbi.nlm.nih.gov/pubmed/29594024
http://dx.doi.org/10.21037/tau.2017.12.28

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861273/
https://www.ncbi.nlm.nih.gov/pubmed/29594024
http://dx.doi.org/10.21037/tau.2017.12.28

Ejemplares similares